Sort   by:  
 Page size 
UnknownIn Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.
Not available
S-EPMC4892517 | biostudies-literature
UnknownLong-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen.
Not available
S-EPMC10755216 | biostudies-literature
UnknownLocoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis.
Not available
S-EPMC5468752 | biostudies-literature
UnknownManagement and outcome of primary CNS lymphoma in the modern era: An LOC network study.
Not available
S-EPMC7238921 | biostudies-literature
UnknownCharacterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France.
Not available
S-EPMC12148392 | biostudies-literature
UnknownDeep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab.
Not available
S-EPMC7862054 | biostudies-literature
UnknownHigher levels of host-cell DNA methylation markers ZNF582 and ASCL1 on anal smears are predictive for progression to anal cancer in patients with previous high-grade lesions.
Not available
S-EPMC12508813 | biostudies-literature
UnknownA genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study.
Not available
S-EPMC6682213 | biostudies-literature
UnknownP923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORLD PHYSICIAN’S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
Not available
S-EPMC10430900 | biostudies-literature
UnknownNeoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial.
Not available
S-EPMC7392746 | biostudies-literature
Sort   by:  
 Page size